Rheumatology

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - British Society for Rheumatology and British Health Professionals in Rheumatology Annual Conference

IL-6 Receptor Inhibition in Rheumatoid Arthritis: New Insights from Clinical Trials

Glasgow, UK / April 28-May 1, 2009

Glasgow - Between 30% and 40% of patients with rheumatoid arthritis (RA) fail to respond to currently available disease-modifying anti-rheumatic drugs (DMARDs) and biologic agents, creating a need for new agents that target novel...

PHYSICIAN PERSPECTIVE Viewpoint based on presentations from the 64th Annual Meeting of the Canadian Rheumatology Association

Long-term Effectiveness of Tumour Necrosis Factor Inhibitors in the Treatment of Psoriatic Arthritis

Kananaskis, Alberta / February 18-21, 2009

INTRODUCTION Psoriatic arthritis (PsA) is a chronic progressive inflammatory disease that affects both the skin and the joints. More severe forms can lead to progressive joint destruction and bony fusion with patients experiencing...

FRONTLINE - Based on Sessions from the 64th Annual Meeting of the Canadian Rheumatology Association

Rheumatology

Kananaskis, Alberta / February 18-21, 2009

Spondyloarthropathies and Comorbidities: Enhancing Patient Care by Increasing Interspecialty Awareness Editorial Overview: Michel Zummer, MD, FRCPC Head, Division of Rheumatology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec The...

ABSTRACTS in PERSPECTIVE based on presentation from the 72nd Annual Meeting of the American College of Rheumatology

Perspectives on IL-6 Inhibition in Rheumatoid Arthritis: An Analysis of Recent Data

San Francisco, California / October 24-29, 2008

EDITORIAL OVERVIEW: Louis Bessette, MD, MSc, FRCPC Clinical Professor, Department of Medicine, Université Laval, Rheumatologist, CHUQ-Centre hospitalier de l’Université Laval, Quebec City, Quebec Biologic therapy for rheumatoid arthritis...

ABSTRACTS in PERSPECTIVE based on presentations from the 72nd Annual Meeting of the American College of Rheumatology

The Case for Early Combination Therapy in Rheumatoid Arthritis: Reviewing the TNF Inhibition Evidence to Date

San Francisco, California / October 24-29, 2008

EDITORIAL REVIEW: Michael R. Starr, MD, FRCPC Division of Rheumatology, Montreal General Hospital, Assistant Professor of Medicine, McGill University, Montreal, Quebec Rheumatoid arthritis (RA) affects more than 2 million adults in the US,...

JOURNAL CLUB 2008 - Rheumatology

Achieving Drug-free Remission in Rheumatoid Arthritis: The BeSt Strategy

Editorial Overview: Cornelia F. Allaart, MD, PhD Associate Professor, Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands The newly published data from the BeSt (Behandel Strategieën) study, which validated...

PHYSICIAN PERSPECTIVE - Based on the following articles: Arthritis Rheum 2006;54:2665-73, Ann Rheum Dis 2008 Oct 24;Epub ahead of print.

Developments in the Diagnosis and Treatment of Psoriatic Arthritis

November 2008

Editorial review: Dafna D. Gladman, MD, FRCPC Senior Scientist, Toronto Western Research Institute, Centre for Prognosis Studies in the Rheumatic Diseases, UHN-Toronto Western Hospital, Professor of Medicine, University of Toronto,...

ABSTRACTS in PERSPECTIVE based on presentations from the 72nd Annual Meeting of the American College of Rheumatology

Searching for Optimal Anti-TNF Therapy for RA / Psoriatic Arthritis, Ankylosing Spondylitis and TNF Inhibition

San Francisco, California / October 24-29, 2008

EDITORIAL REVIEW: Majed M. Khraishi, MD, FRCPC Medical Director (Rheumatology), Nexus Clinical Research, Professor of Medicine, Memorial University of Newfoundland, St. John’s, Newfoundland SEARCHING FOR OPTIMAL ANTI-TNF THERAPY FOR...

72nd Annual Meeting of the American College of Rheumatology

Remission as a Goal of Anti-TNF Therapy for Rheumatoid Arthritis

San Francisco, California / October 24-29, 2008

San Francisco - After more than a decade of clinical use, inhibitors of tumour necrosis factor alpha (TNFa) continue to have a profound influence on the management of rheumatoid arthritis (RA). Initially recommended only after failure of...

72nd Annual Meeting of the American College of Rheumatology

Expanding Treatment Options for Rheumatoid Arthritis

San Francisco, California / October 24-29, 2008

San Francisco - Biologics offer a wide and increasing range of options over the disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis. Studies have demonstrated that tumour necrosis factor-alpha (TNFa)...

PAGE 5 OF 7   1 2 3 4 5 6 7